Homecare HomebaseSM (HCHB) the nation’s #1 software for home-based care, has announced a new partnership with CipherHealth, industry leader in healthcare engagement software, to offer exceptional patient outreach for the growing home health and hospice industry.
HCHB has long been a leader in interoperability and automation to help home-based care agencies streamline processes and maximize clinical resources. With increasing federal regulation and the challenges of COVID-19, the collaboration with CipherHealth is perfectly-timed to help agencies better manage a wide range of patient engagement and communications needs. Their proven solutions not only produce double-digit reductions in hospital readmissions, they also save time, money and critical staff resources.
CipherHealth’s patient engagement platform enables seamless care transitions using customized call, text and email communication with patients throughout their episode of care and beyond. This includes regular patient status checks, initial home visit confirmations and diagnostic-centric outreach to help meet specific diagnosis-related needs. If issues or concerns arise, agencies are immediately notified and can act quickly to resolve patient concerns.
Receive Updates on Patient Engagement
“As the healthcare industry goes through rapid transformation due to COVID-19, homebound patients and their caregivers are dealing with a new set of challenges never seen before. Home health agencies are recognizing the need for integrated technology that automates the myriad communications, scheduling and monitoring tasks so that clinicians have more quality time with their patients to drive better outcomes” said CipherHealth Vice President of Strategic Partnerships, John Banks Powell. “CipherHealth is excited to partner with Homecare Homebase to power these digital touchpoints and interactions for a more seamless patient and clinician experience.”
Homecare Homebase Chief Strategy Officer Scott Pattillo described the CipherHealth partnership as “a perfect fit” to match HCHB’s intense focus on streamlined processes, operational efficiencies and clinical excellence. “When we find a solution that dovetails so nicely with our core platform, we’re eager to add even more value for our customers. Our growing roster of strategic partners is helping us transform the industry and empower exceptional home-based care.”
CipherHealth is an award-winning healthcare technology company that delivers a full suite of scalable and flexible patient engagement solutions for healthcare organizations to keep patients, staff, families and communities up to date and informed about their preventative, acute or elective care — whether it is in a hospital, clinic, facility, at home or anywhere in between. To learn more about how CipherHealth is helping healthcare organizations get back on the road to recovery, check out its two-part educational webinar “Roadmap to Recovery: Communication Strategies to Maximize Revenue & Ensure Continuity of Care.”
About Homecare Homebase, LLC
Homecare Homebase (HCHB) is a Dallas-based software leader offering hosted, cloud-based solutions to streamline operations, simplify compliance and boost clinical and financial outcomes for homecare and hospice agencies. Our customized mobile solutions enable real-time, wireless data exchange and communication between field clinicians, physicians and office staff for better care, more accurate reporting and faster payment. Founded by industry veterans in 1999, the company is now part of the Hearst Health Network.
About Hearst Health
The mission of Hearst Health is to help guide the most important care moments by delivering vital information into the hands of everyone who touches a person’s health journey. Each year in the U.S., care guidance from Hearst Health reaches 85 percent of discharged patients, 205 million insured individuals, 103 million home health visits and 3.2 billion dispensed prescriptions. The Hearst Health network includes FDB (First Databank), Zynx Health, MCG, Homecare Homebase and MHK (formerly MedHOK). Hearst also holds a minority interest in the precision medicine and oncology analytics company M2Gen.